ArsenalBio

ArsenalBio

Latest funding
$85,000,000
Venture capital (Series A) - 2019
Osage Venture Partners Euclidean Capital Parker Institute for Cancer Immunotherapy +4
Team Size
1–10
Employees
$85,000,000 Venture capital (Series A)
Pulse 2.0

ArsenalBio Raises $85 Million In Funding To Develop Immune Cell Therapies